•
Dec 31, 2019

Stryker Q4 2019 Earnings Report

Stryker's Q4 2019 performance showcased strong growth, with net sales increasing and adjusted EPS exceeding guidance.

Key Takeaways

Stryker reported an 8.8% increase in net sales, reaching $4.1 billion, and an 8.0% rise in organic net sales for Q4 2019. The adjusted EPS increased by 14.2% to $2.49, surpassing the high end of the guidance range. The company's performance was driven by growth across all business segments and geographies, contributing to an excellent finish to the year.

Net sales increased by 8.8% to $4.1 billion.

Organic net sales grew by 8.0%.

Adjusted operating income margin expanded by 80 bps to 28.3%.

Adjusted EPS increased by 14.2% to $2.49, exceeding guidance.

Total Revenue
$4.13B
Previous year: $3.8B
+8.8%
EPS
$2.49
Previous year: $2.18
+14.2%
Organic Net Sales Growth
8%
Gross Profit
$2.7B
Previous year: $2.46B
+10.1%
Cash and Equivalents
$4.34B
Previous year: $3.62B
+19.9%
Free Cash Flow
$536M
Previous year: $892M
-39.9%
Total Assets
$30.2B
Previous year: $27.2B
+10.8%

Stryker

Stryker

Stryker Revenue by Segment

Stryker Revenue by Geographic Location

Forward Guidance

Stryker anticipates organic net sales growth to be between 6.5% and 7.5% in 2020, with adjusted net earnings per diluted share expected to range from $9.00 to $9.20. For the first quarter of 2020, the company projects adjusted net earnings per diluted share to be in the range of $2.05 to $2.10.

Revenue & Expenses

Visualization of income flow from segment revenue to net income